1.Spatial metabolomics combined with machine learning in colon cancer diagnosis research.
Ling WENG ; Huanhuan WANG ; Chunxiang ZHAI ; Qi WANG ; Yanyan GUO ; Ziyi ZHONG ; Chenying MA ; Jing WANG
Journal of Pharmaceutical Analysis 2025;15(8):101367-101367
Image 1.
2.Etiological analysis of influenza-like cases in Taizhou City, Zhejiang Province from 2013 to 2022
Ziyi WANG ; Weiwei SHEN ; Hongzhu WANG ; Jian WENG
Shanghai Journal of Preventive Medicine 2024;36(4):348-351
ObjectiveTo analyze the etiological results of influenza-like case surveillance in Taizhou, Zhejiang Province from 2013 to 2022, to timely understand the epidemic trend of influenza viruses and the change rule of dominant virus strains, and to provide reference for the prevention and control of influenza in this region. MethodsInfluenza virus nucleic acid was detected by real-time PCR in 24 183 influenza-like cases. ResultsThe positive rate of influenza virus in 24 183 samples was 18.43%, the highest positive type was seasonal H3 (37.34%). There was no a significant difference in positive rate between different genders (χ2=0.148, P=0.701). There was significant difference in the positive rate among different age groups (χ2=496.626, P<0.001), and the highest positive rate was found in the 25‒59 age group (22.56%). The positive rate in different years was statistically significant (χ2=1 670.922, P<0.001). The positive rate from 2013 to 2019 showed an upward trend (χ2=30.559, P<0.001). The lowest positive rate was in 2020 (0.04%), and the positive rate from 2021 to 2022 showed an upward trend (χ2=304.465, P<0.001). The dominant strains were different in different monitoring years. There was a significant difference in the positive rate of influenza in different months (χ2=1 652.455, P<0.001), and the peak of influenza was mainly concentrated in December‒March and July‒August. ConclusionFrom 2013 to 2022, the positive rate of influenza virus in Taizhou showed a wavy dynamic change, and the dominant strains were different in different years, presenting alternate epidemic characteristics. It is necessary to strengthen the etiological surveillance of influenza virus and improve the prevention and control measures with influenza vaccine.
3.Tracheal diverticula discovered during surgery: a report of 2 cases and literature review
Wen HE ; Jianhua GU ; Xujian XING ; Ziyi WENG ; Jian FEI
Journal of Surgery Concepts & Practice 2023;28(4):383-387
To analyze the reasons why tracheal diverticula is easy to be missed or misdiagnosed in the diagnosis and treatment of thyroid tumors, and to strengthen the understanding of the clinical characteristics of the disease. The reasons of the misdiagnosis and missed diagnosis in similar cases were analyzed, and the anatomy, differential diagnosis, and examination methods by reviewing the relevant literature in the past 20 years were further analyzed. At the same time, a retrospective analysis was carried out on two recent clinical cases of tracheal diverticula discovered during surgery. Tracheal diverticula is easily confused with thyroid tumor and may be misdiagnosed for the following reasons: tracheal diverticula is asymptomatic in most patients; symptomatic tracheal diverticula has similar clinical symptoms to thyroid nodules; lack of character in imaging findings. General surgeons should improve their awareness and vigilance of tracheal diverticula. Neck CT should be listed as a routine examination before thyroid-related surgery.
4.Etiological analysis of acute respiratory tract infection in Taizhou of Zhejiang Province from 2020 to 2021
Ziyi WANG ; Jian WENG ; Hongzhu WANG ; Ying SHENG ; Guixia LI ; Xikai CHEN ; Congcong LI ; Yaya GUAN ; Ying SHENG ; Weiwei SHEN
Shanghai Journal of Preventive Medicine 2022;34(7):638-641
ObjectiveWe examined the principal respiratory pathogens in patients with acute respiratory tract infection in Taizhou, Zhejiang Province during 2020‒2021 to provide evidence for prevention, diagnosis and treatment of acute respiratory tract infection. MethodsFrom September 2020 to August 2021, a total of 2 831 cases with acute respiratory tract infection were collected from two influenza sentinel surveillance hospitals in Taizhou, which had then received the examination of 22 respiratory pathogens by multiple fluorescence quantitative PCR. ResultsThe total positive rate of respiratory pathogens in 2 831 samples was 14.13%, among which enterovirus (7.77%) and respiratory syncytial virus (1.59%) were the principal pathogens. Except enterovirus, there was no significant difference in the positive rate of pathogens detected by gender(P>0.05). Moreover, there was significant difference in pathogens by age (P<0.05), with the highest positive rate in 0‒4 years(35.21%). There was also significant difference in pathogens by seasons (P<0.05), with the highest positive rate in summer(20.54%). ConclusionThe positive rate of acute respiratory tract infection decreases significantly, compared with that before the COVID-19 epidemic. The differences in the positive rate differ significantly by age and seasons. Comprehensive consideration of diverse factors before diagnosis and the utilization of multiple fluorescent quantitative PCR can quickly and effectively determine the pathogens in the early stage of infection. Our findings may provide certain support for the diagnosis and treatment of acute respiratory infections in the context of COVID-19 in Taizhou.
5.Reevaluation of equivocal HER2 status detected by immunohistochemistry according to the 2019 guidelines for HER2 detection
Weiming XU ; Lingna ZHANG ; Haili JIN ; Jingjing ZHOU ; Ziyi WANG ; Shouxiang WENG ; Yujing LI ; Pin ZHOU ; Meifu GAN
Chinese Journal of Pathology 2020;49(11):1152-1157
O bjective To understand the effects and clinical significance of the 2019 guidelines for the human epidermal growth factor receptor 2 (HER2) detection. Methods:According to the 2014 guidelines, 548 cases of invasive breast cancer with equivocal HER2 (2+) detected by immunohistochemistry (IHC) in Taizhou Enze Medical Center, Zhejiang Province, China from 2013 to 2019 were selected. The results of IHC and HER2/CEPl7 double-probe were reevaluated and divided into groups according to the 2019 guidelines for the comparative analysis.Results:Among the 548 IHC HER2 (2+) invasive breast cancers, the number of positive, equivocal and negative cases for HER2 were 96 (17.52%), 81 (14.78%) and 371 (67.70%), respectively, according to the 2014 guidelines. However, according to the 2019 guidelines, 10 cases (1.82%) were reclassified as IHC 1+, 2 cases in the group 2 were reclassified as negative, and all the originally equivocal cases in group 4 were reclassified as negative. Finally, the total number of positive and negative cases for HER2 were 94 (17.15%) and 454 (82.85%), respectively.Conclusions:After applying the 2019 guidelines, the number of IHC 2+ cases decreases, and the positive rate for HER2 also decreases slightly due to the reevaluation change in groups 2 and 4, leading to reclassification of the cases that were deemed equivocal according to the 2014 guidelines. In general, the new 2019 guidelines are more reasonable and easier to use.

Result Analysis
Print
Save
E-mail